Apogee Therapeutics, Inc. (APGE)
135.08
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 14:29
Apogee Therapeutics Cash from Operations (TTM) : -243.89M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -243.89M |
| March 31, 2026 | -234.54M |
| December 31, 2025 | -227.45M |
| September 30, 2025 | -232.48M |
| June 30, 2025 | -220.74M |
| March 31, 2025 | -188.02M |
| December 31, 2024 | -171.17M |
| September 30, 2024 | -133.21M |
| Date | Value |
|---|---|
| June 30, 2024 | -110.57M |
| March 31, 2024 | -95.84M |
| December 31, 2023 | -74.76M |
| September 30, 2023 | -54.20M |
| June 30, 2023 | -41.55M |
| March 31, 2023 | -26.98M |
| December 31, 2022 | -16.43M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Cogent Biosciences, Inc. | -307.54M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Intellia Therapeutics, Inc. | -346.64M |
| Revolution Medicines, Inc. | -1.223B |
| Erasca, Inc. | -98.02M |